Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 119

1.

Diagnosis and Management of Anaplastic Thyroid Cancer.

Chintakuntlawar AV, Foote RL, Kasperbauer JL, Bible KC.

Endocrinol Metab Clin North Am. 2019 Mar;48(1):269-284. doi: 10.1016/j.ecl.2018.10.010. Review.

PMID:
30717908
2.

Utility of adjuvant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma.

Miller KC, Marinelli JP, Van Gompel JJ, Link MJ, Janus JR, Foote RL, Price KA, Garcia J, Rivera M, Chintakuntlawar AV.

Head Neck. 2018 Dec 10. doi: 10.1002/hed.25558. [Epub ahead of print]

PMID:
30536472
3.

Treatment outcomes of squamous cell carcinoma of the oral cavity in young adults.

Gamez ME, Kraus R, Hinni ML, Moore EJ, Ma DJ, Ko SJ, Rwigema JCM, McGee LA, Halyard MY, Buras MR, Foote RL, Patel SH.

Oral Oncol. 2018 Dec;87:43-48. doi: 10.1016/j.oraloncology.2018.10.014. Epub 2018 Oct 22.

PMID:
30527242
4.

Radiation-Related Alterations of Taste Function in Patients With Head and Neck Cancer: a Systematic Review.

Deshpande TS, Blanchard P, Wang L, Foote RL, Zhang X, Frank SJ.

Curr Treat Options Oncol. 2018 Nov 9;19(12):72. doi: 10.1007/s11864-018-0580-7. Review.

5.

Prospective Immunophenotyping of CD8+ T Cells and Associated Clinical Outcomes of Patients With Oligometastatic Prostate Cancer Treated With Metastasis-Directed SBRT.

Evans JD, Morris LK, Zhang H, Cao S, Liu X, Mara KC, Stish BJ, Davis BJ, Mansfield AS, Dronca RS, Iott MJ, Kwon ED, Foote RL, Olivier KR, Dong H, Park SS.

Int J Radiat Oncol Biol Phys. 2019 Jan 1;103(1):229-240. doi: 10.1016/j.ijrobp.2018.09.001. Epub 2018 Sep 8.

PMID:
30205124
6.

Magnitude of benefit for adjuvant radiotherapy following minimally invasive surgery in intermediate to high risk HPV-positive oropharyngeal squamous cell carcinoma.

Pasalic D, Funk RK, García JJ, Price DL, Price KA, Harmsen WS, Patel SH, Young GD, Foote RL, Moore EJ, Ma DJ.

Oral Oncol. 2018 Jul;82:181-186. doi: 10.1016/j.oraloncology.2018.05.026. Epub 2018 Jun 6.

PMID:
29909895
7.

Esthesioneuroblastoma with distant metastases: Systematic review & meta-analysis.

Marinelli JP, Janus JR, Van Gompel JJ, Link MJ, Foote RL, Lohse CM, Price KA, Chintakuntlawar AV.

Head Neck. 2018 Oct;40(10):2295-2303. doi: 10.1002/hed.25209. Epub 2018 May 13. Review.

PMID:
29756250
8.

NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.

Colevas AD, Yom SS, Pfister DG, Spencer S, Adelstein D, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Eisele DW, Fenton M, Foote RL, Gilbert J, Gillison ML, Haddad RI, Hicks WL, Hitchcock YJ, Jimeno A, Leizman D, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2018 May;16(5):479-490. doi: 10.6004/jnccn.2018.0026.

PMID:
29752322
9.

Protons vs Photons for Brain and Skull Base Tumors.

Ahmed SK, Brown PD, Foote RL.

Semin Radiat Oncol. 2018 Apr;28(2):97-107. doi: 10.1016/j.semradonc.2017.11.001. Review.

PMID:
29735196
10.

Comparing Intensity-Modulated Proton Therapy With Intensity-Modulated Photon Therapy for Oropharyngeal Cancer: The Journey From Clinical Trial Concept to Activation.

Frank SJ, Blanchard P, Lee JJ, Sturgis EM, Kies MS, Machtay M, Vikram B, Garden AS, Rosenthal DI, Gunn GB, Fuller CD, Hutcheson K, Lai S, Busse PM, Lee NY, Lin A, Foote RL.

Semin Radiat Oncol. 2018 Apr;28(2):108-113. doi: 10.1016/j.semradonc.2017.12.002.

11.

In Reply to Garden.

Routman DM, Foote RL, Ma DJ, Patel SH, Hinni ML.

Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1296-1297. doi: 10.1016/j.ijrobp.2018.01.007. No abstract available.

PMID:
29722671
12.

Long-term tumor control following stereotactic radiosurgery for jugular paraganglioma using 3D volumetric segmentation.

Patel NS, Carlson ML, Pollock BE, Driscoll CLW, Neff BA, Foote RL, Lohse CM, Link MJ.

J Neurosurg. 2018 Apr 1:1-9. doi: 10.3171/2017.10.JNS17764. [Epub ahead of print]

PMID:
29652232
13.

External beam radiation therapy for advanced/unresectable malignant paraganglioma and pheochromocytoma.

Breen W, Bancos I, Young WF Jr, Bible KC, Laack NN, Foote RL, Hallemeier CL.

Adv Radiat Oncol. 2017 Nov 22;3(1):25-29. doi: 10.1016/j.adro.2017.11.002. eCollection 2018 Jan-Mar.

14.

Sentinel lymph node biopsy in Merkel cell carcinoma: The Mayo Clinic experience of 150 patients.

Sims JR, Grotz TE, Pockaj BA, Joseph RW, Foote RL, Otley CC, Weaver AL, Jakub JW, Price DL.

Surg Oncol. 2018 Mar;27(1):11-17. doi: 10.1016/j.suronc.2017.10.005. Epub 2017 Oct 26.

PMID:
29549898
15.

Data collection of patient outcomes: one institution's experience.

Whitaker TJ, Mayo CS, Ma DJ, Haddock MG, Miller RC, Corbin KS, Neben-Wittich M, Leenstra JL, Laack NN, Fatyga M, Schild SE, Vargas CE, Tzou KS, Hadley AR, Buskirk SJ, Foote RL.

J Radiat Res. 2018 Mar 1;59(suppl_1):i19-i24. doi: 10.1093/jrr/rry013.

16.

Proton Therapy for Head and Neck Cancers.

Blanchard P, Gunn GB, Lin A, Foote RL, Lee NY, Frank SJ.

Semin Radiat Oncol. 2018 Jan;28(1):53-63. doi: 10.1016/j.semradonc.2017.08.004. Review.

PMID:
29173756
17.

Survival in Response to Multimodal Therapy in Anaplastic Thyroid Cancer.

Prasongsook N, Kumar A, Chintakuntlawar AV, Foote RL, Kasperbauer J, Molina J, Garces Y, Ma D, Wittich MAN, Rubin J, Richardson R, Morris J, Hay I, Fatourechi V, McIver B, Ryder M, Thompson G, Grant C, Richards M, Sebo TJ, Rivera M, Suman V, Jenkins SM, Smallridge RC, Bible KC.

J Clin Endocrinol Metab. 2017 Dec 1;102(12):4506-4514. doi: 10.1210/jc.2017-01180.

PMID:
29029287
18.

Photon and Proton Radiation Therapy Utilization in a Population of More Than 100 Million Commercially Insured Patients.

Waddle MR, Sio TT, Van Houten HK, Foote RL, Keole SR, Schild SE, Laack N, Daniels TB, Crown W, Shah ND, Miller RC.

Int J Radiat Oncol Biol Phys. 2017 Dec 1;99(5):1078-1082. doi: 10.1016/j.ijrobp.2017.07.042. Epub 2017 Aug 2.

PMID:
28939229
19.

Relapse Rates With Surgery Alone in Human Papillomavirus-Related Intermediate- and High-Risk Group Oropharynx Squamous Cell Cancer: A Multi-Institutional Review.

Routman DM, Funk RK, Tangsriwong K, Lin A, Keeney MG, García JJ, Zarka MA, Lewis JT, Stoddard DG, Moore EJ, Day CN, Zhai Q, Price KA, Lukens JN, Swisher-McClure S, Weinstein GS, O'Malley BW Jr, Foote RL, Ma DJ.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):938-946. doi: 10.1016/j.ijrobp.2017.06.2453. Epub 2017 Jun 28. Erratum in: Int J Radiat Oncol Biol Phys. 2018 Apr 1;100(5):1304.

PMID:
28847412
20.

NCCN Guidelines Insights: Head and Neck Cancers, Version 2.2017.

Adelstein D, Gillison ML, Pfister DG, Spencer S, Adkins D, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Eisele DW, Fenton M, Foote RL, Gilbert J, Haddad RI, Hicks WL Jr, Hitchcock YJ, Jimeno A, Leizman D, Lydiatt WM, Maghami E, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rocco J, Rodriguez CP, Shah JP, Weber RS, Witek M, Worden F, Yom SS, Zhen W, Burns JL, Darlow SD.

J Natl Compr Canc Netw. 2017 Jun;15(6):761-770. doi: 10.6004/jnccn.2017.0101.

PMID:
28596256
21.

Outcomes and patterns of failure for sinonasal undifferentiated carcinoma (SNUC): The Mayo Clinic Experience.

Gamez ME, Lal D, Halyard MY, Wong WW, Vargas C, Ma D, Ko SJ, Foote RL, Patel SH.

Head Neck. 2017 Sep;39(9):1819-1824. doi: 10.1002/hed.24834. Epub 2017 May 31.

PMID:
28561906
22.

Gamma knife radiosurgery for the treatment of uveal melanoma and uveal metastases.

Reynolds MM, Arnett AL, Parney IF, Kumar R, Laack NN, Maloney PR, Kozelsky TF, Garces YI, Foote RL, Pulido JS.

Int J Retina Vitreous. 2017 May 29;3:17. doi: 10.1186/s40942-017-0070-2. eCollection 2017.

23.

Volume-Staged Stereotactic Radiosurgery for Intracranial Arteriovenous Malformations: Outcomes Based on an 18-Year Experience.

Pollock BE, Link MJ, Stafford SL, Lanzino G, Garces YI, Foote RL.

Neurosurgery. 2017 Apr 1;80(4):543-550. doi: 10.1093/neuros/nyw107.

PMID:
28362923
24.

The Risk of Radiation-Induced Tumors or Malignant Transformation After Single-Fraction Intracranial Radiosurgery: Results Based on a 25-Year Experience.

Pollock BE, Link MJ, Stafford SL, Parney IF, Garces YI, Foote RL.

Int J Radiat Oncol Biol Phys. 2017 Apr 1;97(5):919-923. doi: 10.1016/j.ijrobp.2017.01.004. Epub 2017 Jan 9.

PMID:
28333013
25.

Expression of PD-1 and PD-L1 in Anaplastic Thyroid Cancer Patients Treated With Multimodal Therapy: Results From a Retrospective Study.

Chintakuntlawar AV, Rumilla KM, Smith CY, Jenkins SM, Foote RL, Kasperbauer JL, Morris JC, Ryder M, Alsidawi S, Hilger C, Bible KC.

J Clin Endocrinol Metab. 2017 Jun 1;102(6):1943-1950. doi: 10.1210/jc.2016-3756.

PMID:
28324060
26.

Risk of Delayed Lymph Node Metastasis in Clinically N0 Esthesioneuroblastoma.

Peacock JG, Harmsen WS, Link MJ, Van Gompel JJ, Giannini C, Olsen KD, Garces YI, Neben Wittich MA, Ma DJ, Park SS, Foote RL.

J Neurol Surg B Skull Base. 2017 Feb;78(1):68-74. doi: 10.1055/s-0036-1584904. Epub 2016 Jul 6.

27.

Hyperbaric Oxygen as Radiation Sensitizer for Locally Advanced Squamous Cell Carcinoma of the Oropharynx: A Phase 1 Dose-Escalation Study.

Hartford AC, Davis TH, Buckey JC, Foote RL, Sinesi MS, Williams BB, Fariss AK, Schaner PE, Claus PL, Okuno SH, Hussey JR, Clarke RE.

Int J Radiat Oncol Biol Phys. 2017 Mar 1;97(3):481-486. doi: 10.1016/j.ijrobp.2016.10.048. Epub 2016 Nov 15.

PMID:
28126298
28.

Survey of current practices from the International Stereotactic Body Radiotherapy Consortium (ISBRTC) for head and neck cancers.

Karam I, Yao M, Heron DE, Poon I, Koyfman SA, Yom SS, Siddiqui F, Lartigau E, Cengiz M, Yamazaki H, Hara W, Phan J, Vargo JA, Lee V, Foote RL, Harter KW, Lee NY, Sahgal A, Lo SS.

Future Oncol. 2017 Mar;13(7):603-613. doi: 10.2217/fon-2016-0403. Epub 2016 Nov 15.

PMID:
27842456
29.

Stereotactic Radiosurgery for Cystic Vestibular Schwannomas.

Frisch CD, Jacob JT, Carlson ML, Foote RL, Driscoll CL, Neff BA, Pollock BE, Link MJ.

Neurosurgery. 2017 Jan 1;80(1):112-118. doi: 10.1227/NEU.0000000000001376.

PMID:
27509069
30.

Head and Neck Soft Tissue Sarcomas Treated with Radiation Therapy.

Vitzthum LK, Brown LC, Rooney JW, Foote RL.

Rare Tumors. 2016 Jun 28;8(2):6165. doi: 10.4081/rt.2016.6165. eCollection 2016 Jun 28.

31.

Establishing quality indicators for neck dissection: Correlating the number of lymph nodes with oncologic outcomes (NRG Oncology RTOG 9501 and RTOG 0234).

Divi V, Harris J, Harari PM, Cooper JS, McHugh J, Bell D, Sturgis EM, Cmelak AJ, Suntharalingam M, Raben D, Kim H, Spencer SA, Laramore GE, Trotti A, Foote RL, Schultz C, Thorstad WL, Zhang QE, Le QT, Holsinger FC.

Cancer. 2016 Nov 15;122(22):3464-3471. doi: 10.1002/cncr.30204. Epub 2016 Jul 15.

32.

Correlation Between the Severity of Cetuximab-Induced Skin Rash and Clinical Outcome for Head and Neck Cancer Patients: The RTOG Experience.

Bar-Ad V, Zhang QE, Harari PM, Axelrod R, Rosenthal DI, Trotti A, Jones CU, Garden AS, Song G, Foote RL, Raben D, Shenouda G, Spencer SA, Harris J, Le QT.

Int J Radiat Oncol Biol Phys. 2016 Aug 1;95(5):1346-1354. doi: 10.1016/j.ijrobp.2016.03.011. Epub 2016 Mar 26.

33.

Outcomes of patients with loco-regionally recurrent or new primary squamous cell carcinomas of the head and neck treated with curative intent reirradiation at Mayo Clinic.

Curtis KK, Ross HJ, Garrett AL, Jizba TA, Patel AB, Patel SH, Wong WW, Halyard MY, Ko SJ, Kosiorek HE, Foote RL.

Radiat Oncol. 2016 Apr 9;11:55. doi: 10.1186/s13014-016-0630-x.

34.

Comparative analysis of arteriovenous malformation grading scales in predicting outcomes after stereotactic radiosurgery.

Pollock BE, Storlie CB, Link MJ, Stafford SL, Garces YI, Foote RL.

J Neurosurg. 2017 Mar;126(3):852-858. doi: 10.3171/2015.11.JNS151300. Epub 2016 Apr 8.

PMID:
27058199
35.

High-grade transformation of acinic cell carcinoma: an inadequately treated entity?

Chintakuntlawar AV, Shon W, Erickson-Johnson M, Bilodeau E, Jenkins SM, Davidson JA, Keeney MG, Rivera M, Price DL, Moore EJ, Olsen KD, Kasperbauer JL, Foote RL, Price KA, García JJ.

Oral Surg Oral Med Oral Pathol Oral Radiol. 2016 May;121(5):542-549.e1. doi: 10.1016/j.oooo.2016.01.011. Epub 2016 Jan 21.

PMID:
27017401
36.

Stereotactic Radiosurgery for Arteriovenous Malformations: The Effect of Treatment Period on Patient Outcomes.

Pollock BE, Link MJ, Stafford SL, Garces YI, Foote RL.

Neurosurgery. 2016 Apr;78(4):499-509. doi: 10.1227/NEU.0000000000001085.

PMID:
26990410
37.

Carbon fiducials for large choroidal melanoma treated with gamma knife radiosurgery.

Reynolds MM, Whitaker TJ, Parney IF, Kozelsky TF, Garces YI, Foote RL, Tryggestad EJ, Pulido JS.

Acta Ophthalmol. 2016 Dec;94(8):e806-e807. doi: 10.1111/aos.12982. Epub 2016 Feb 19. No abstract available.

38.

Establishment of practice standards in nomenclature and prescription to enable construction of software and databases for knowledge-based practice review.

Mayo CS, Pisansky TM, Petersen IA, Yan ES, Davis BJ, Stafford SL, Garces YI, Miller RC, Martenson JA, Mutter RW, Choo R, Hallemeier CL, Laack NN, Park SS, Ma DJ, Olivier KR, Keole SR, Fatyga M, Foote RL, Haddock MG.

Pract Radiat Oncol. 2016 Jul-Aug;6(4):e117-26. doi: 10.1016/j.prro.2015.11.001. Epub 2016 Jan 26. Review.

PMID:
26825250
39.

Risk factors for locoregional relapse after transoral robotic surgery for human papillomavirus-related oropharyngeal squamous cell carcinoma.

Funk RK, Moore EJ, García JJ, Harmsen WS, Stoddard DG, Vencio EF, Foote RL, Price KA, Ma DJ.

Head Neck. 2016 Apr;38 Suppl 1:E1674-9. doi: 10.1002/hed.24298. Epub 2015 Dec 15.

PMID:
26667985
40.

Head and Neck Cancers, Version 1.2015.

Pfister DG, Spencer S, Brizel DM, Burtness B, Busse PM, Caudell JJ, Cmelak AJ, Colevas AD, Dunphy F, Eisele DW, Foote RL, Gilbert J, Gillison ML, Haddad RI, Haughey BH, Hicks WL Jr, Hitchcock YJ, Jimeno A, Kies MS, Lydiatt WM, Maghami E, McCaffrey T, Mell LK, Mittal BB, Pinto HA, Ridge JA, Rodriguez CP, Samant S, Shah JP, Weber RS, Wolf GT, Worden F, Yom SS, McMillian N, Hughes M.

J Natl Compr Canc Netw. 2015 Jul;13(7):847-55; quiz 856.

41.

Cost-effectiveness of proton beam therapy for intraocular melanoma.

Moriarty JP, Borah BJ, Foote RL, Pulido JS, Shah ND.

PLoS One. 2015 May 18;10(5):e0127814. doi: 10.1371/journal.pone.0127814. eCollection 2015.

42.

Negative Sentinel Lymph Node Biopsy in Merkel Cell Carcinoma is Associated with a Low Risk of Same-Nodal-Basin Recurrences.

Grotz TE, Joseph RW, Pockaj BA, Foote RL, Otley CC, Bagaria SP, Weaver AL, Jakub JW.

Ann Surg Oncol. 2015 Nov;22(12):4060-6. doi: 10.1245/s10434-015-4421-7. Epub 2015 Feb 13.

PMID:
25676844
43.

Angiosarcoma of the scalp and face: the Mayo Clinic experience.

Patel SH, Hayden RE, Hinni ML, Wong WW, Foote RL, Milani S, Wu Q, Ko SJ, Halyard MY.

JAMA Otolaryngol Head Neck Surg. 2015 Apr;141(4):335-40. doi: 10.1001/jamaoto.2014.3584.

PMID:
25634014
44.

Failure rate of contemporary low-dose radiosurgical technique for vestibular schwannoma. Clinical article.

Pollock BE, Link MJ, Foote RL.

J Neurosurg. 2013 Dec;119 Suppl:840-4.

PMID:
25077331
45.

Vestibular schwannoma management: Part II. Failed radiosurgery and the role of delayed microsurgery.

Pollock BE, Lunsford LD, Kondziolka D, Sekula R, Subach BR, Foote RL, Flickinger JC.

J Neurosurg. 2013 Dec;119 Suppl:949-55.

PMID:
25077309
46.

Postoperative chemoradiotherapy and cetuximab for high-risk squamous cell carcinoma of the head and neck: Radiation Therapy Oncology Group RTOG-0234.

Harari PM, Harris J, Kies MS, Myers JN, Jordan RC, Gillison ML, Foote RL, Machtay M, Rotman M, Khuntia D, Straube W, Zhang Q, Ang K.

J Clin Oncol. 2014 Aug 10;32(23):2486-95. doi: 10.1200/JCO.2013.53.9163. Epub 2014 Jul 7.

47.

Charged particle therapy versus photon therapy for paranasal sinus and nasal cavity malignant diseases: a systematic review and meta-analysis.

Patel SH, Wang Z, Wong WW, Murad MH, Buckey CR, Mohammed K, Alahdab F, Altayar O, Nabhan M, Schild SE, Foote RL.

Lancet Oncol. 2014 Aug;15(9):1027-38. doi: 10.1016/S1470-2045(14)70268-2. Epub 2014 Jun 26. Review.

PMID:
24980873
48.

Long-term follow-up of stereotactic radiosurgery for head and neck malignancies.

Owen D, Iqbal F, Pollock BE, Link MJ, Stien K, Garces YI, Brown PD, Foote RL.

Head Neck. 2015 Nov;37(11):1557-62. doi: 10.1002/hed.23798. Epub 2014 Aug 1.

49.

Doxepin rinse versus placebo in the treatment of acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy: a phase III, randomized, double-blind trial (NCCTG-N09C6 [Alliance]).

Leenstra JL, Miller RC, Qin R, Martenson JA, Dornfeld KJ, Bearden JD, Puri DR, Stella PJ, Mazurczak MA, Klish MD, Novotny PJ, Foote RL, Loprinzi CL.

J Clin Oncol. 2014 May 20;32(15):1571-7. doi: 10.1200/JCO.2013.53.2630. Epub 2014 Apr 14.

50.

Adjuvant hypofractionated intensity modulated radiation therapy after resection of regional lymph node metastases in patients with cutaneous malignant melanoma of the head and neck.

Hallemeier CL, Garces YI, Neben-Wittich MA, Olivier KR, Shon W, García JJ, Brown PD, Foote RL.

Pract Radiat Oncol. 2013 Apr-Jun;3(2):e71-7. doi: 10.1016/j.prro.2012.06.003. Epub 2012 Jul 10.

PMID:
24674323

Supplemental Content

Loading ...
Support Center